Lorillard
Chapter 4: Environmental Tobacco Smoke and Cancer - Environmental Tobacco Smoke: A Compendium of Technical Information
Fields
- Author
- Smith, C.J.
- Alias
- 88772419/88772433
- Type
- REPT, OTHER REPORT
- BIBL, BIBLIOGRAPHY
- Area
- CROUSE,WILLIAM/BASEMENT GMP
- Litigation
- Stmn/Produced
- Characteristic
- EXTR, EXTRA
- Site
- G10
- Named Organization
- Nas, Natl Academy of Sciences
- Natl Center for Health Statistics
- Natl Research Council
- NCI, Natl Cancer Inst
- Natl Center for Health Statistics
- Master ID
- 88772371/2597
Related Documents:- 88772371-2597 United States Environmental Protection Agency Environmental Tobacco Smoke: A Compendium of Technical Information Comments of the Tobacco Institute 900205 Reviewers' Statements
- 88772372-2379 Comments on Chapter 3
- 88772380-2396 Review of: Environmental Tobacco Smoke A Compendium of Technical Information
- 88772397-2403 Reactions to Environmental Tobacco Smoke: A Compendium of Technical Information Chapter 4: Environmental Tobacco Smoke and Cancer
- 88772404-2418 Comments on Environmental Tobacco Smoke: A Compendium of Technical Information Chapter 4: Environmental Tobacco Smoke and Cancer
- 88772434-2442 Statement
- 88772443-2466 Critique of the Report Entitled Environmental Tobacco Smoke: A Compendium of Technical Information U.S. Environmental Protection Agency Chapters 5-8
- 88772467-2481 Environmental Tobacco Smoke: A Compendium of Technical Information Technical Review
- 88772482-2494 Review of: Environmental Tobacco Smoke A Compendium of Technical Information
- 88772495-2500 Comments by Dr. Guy B. Oldaker III on Chapter 5 Measuring Exposure to Environmental Tobacco Smoke
- 88772501-2504 Comments with References on 'measuring Exposure to Environmental Tobacco Smoke'
- 88772505-2512 Comments by Dr. Guy B. Oldaker III on Chapter 6 Exposures to Air Pollutants
- 88772513-2530 Comments by Dr. Guy B. Oldaker III on Chapter 7 Exposure Assessment in Passive Smoking
- 88772531-2533 Comments on Chapter 7: Exposure Assessment in Passive Smoking
- 88772534-2540 Review of Chapter 8 by D. Hoffmann, K.D. Brunnemann, and N. J. Haley of the Draft Compendium of Technical Information on Ets Edited by the Environmental Protection Agency
- 88772541-2553 Critique of Environmental Tobacco Smoke: A Compendium of Technical Information Chapter 9: the Effects of Passive Smoking and Day Care on Respiratory Illnesses in Children
- 88772554-2572 Evaluation of Appendix 10: Economic Justification for No Smoking Policies at the Worksite
- 88772573-2584 Economic Justification for Worksite Smoking Policies
- 88772585-2596 Review of: Environmental Tobacco Smoke A Compendium of Technical Information
- Named Person
- Azzarone
- Banks
- Broder, S.
- Caporaso
- Cohen
- Davis, D.L.
- Doll, R.
- Dosaka
- Feinstein
- Ford
- Goodman
- Heighway
- Joishy
- Kellermann
- Lilienfeld
- Mackintosh
- Markman
- Mcduffie
- Mcfarlane
- Menkes
- Miyamoto
- Mottironi
- Newman
- Ooi
- Perusse
- Rudiger
- Schneiderman, M.A.
- Sidney
- Tanaka
- Tokuhata
- Wagener, D.K.
- Wells
- Wynder
- Yokota
- Zeigler
- Banks
- Date Loaded
- 12 Feb 1999
- UCSF Legacy ID
- ufh30e00
Document Images
CHAPTER 4: ENVIRONMENTAL TOBACCO
SMOKE AND CANCER
fl
CARR J. SMITH, PH.D.
SENIOR SCIENTIST
L

ENVIRONMENTAL TOBACCO SMOKE:
A COMPENDIUM OF TECHNICAL INFORMATION
Section/Page/Line Specific Comments
ETS and Cancer/Paae 41/Line 14
The phrase 'in the general population" needs to be clarified.- There are
significant differences in histologic distribution between males and females
(1)-
ETS and Cancer/Page 41/Line 17
The sentence 'Bronchioloalveolar cell carcinoma represents about 5 percent of
the remaining lung cancers' is incorrect. Five percent of ten percent is
0.5%. This cancer represents from 1.1 to 9.0% of lung cancers (2).
ETS and Cancer/Page 41/Line 24 -
The statement, 'Most of the early evidence indicated that tobacco smoke was a
potent respiratory carcinogen" deserves comment. Toba,:co smoke has not been
shown to induce lung cancer in experimental animals.
0D
OQ
~
~
N
~
1 p

ENVIRONMENTAL TOBACCO SMOKE:
A COMPENDItM OF TECHNICAL INFORMAT[ON
Section/Page/Line
Specific Conwents
ETS and Cancer/Paae 41/Line 41-42
The statement "Agents other than tobacco smoke may also cause lung cancer, and
cases occur in lifelong nonsmokers" implies that lung cancer is unusual in
nonsmokers. M. A. Schneiderman and D. L. Davis, National Academy of Sciences,
and D. K. Wagener, National Center for Health Statistics (3) recently made the
following comment:
"If these estimates are accurate, only colon and prostate cancers in men
(mortality rates, 21.4 and 23.5 per 100,000, respectively) and colon and
breast cancers in women (15.7 and 27.3 per 100,000, re;:pectively) had higher
mortality rates than did non-smoking-attributable lung cancer for both blacks
and whites.`
Further, blacks might be at higher risk than whites for non-smoking-_
attributable lung cancer, the computed residual "rate" being 67% higher in
black men than that in white men and 16% higher in black women than that in
white women.
As computed herein, non-smoking-attributable lung cancer is one of the most
common causes of cancer mortality.... "
2

ENYIRONMENTAL TOBACCO SMOKE:
A COMPENDIUM OF TECHNICAL INFORMAT[ON
Section/Page/Line Specific Comwents
ETS and Cancer/Page 41LLine 48
Line 48 states that "many other occupational agents are suspect respiratory
carcinogens'. The list of occupational exposures not mentioned that have been
associated with increased lung cancer risk includes:
Welding (4)
Painting (5)
Pesticides (6)
Diesel Exhaust (7)
Working in foundries (8-10)
Ceramic and pottery workers (11-12)
Rubber workers (13)
Herbicides (14)
t
r.
0,
3
L.

ENVIRONNENTAL TOBACCO SNOKE:
A CONPENDIUN OF TECHNICAL INFORMAT[ON
`
Section/Page/Line Specific Coments
ETS and Cancer/Pa4e 42/Line 2
The statement "a clear pattern of genetic susceptibility to lung cancer has
not been demonstrated" is incorrect.
Tokuhata and Lilienfeld (15,16) first observed the familial aggregation of
lung cancer in 1963. In the absence of smoking, they 1'ound.the relative lung
cancer mortality rate among first-degree relatives of lung cancer patients to
be 2.7 times higher than that among relatives of controls. 0oi et al. (17)
reported a 2.4-fold greater.risk among relatives of probands after controlling
for the effects of age, sex, and environmental factors Samet et al. (18)
have shown a 5.3-fold increase in adjusted risk in individuals with a parental
history of lung cancer. A recent study by NcDuffie et al. (19) also
demonstrated a two-fold increase in lung cancer risk fur relatives of probands
in a Canadian population.
Further evidence for a potential familial link was provided by Joishy-et al.
(20) in 1977. They reported the occurrence of alveola'r cell carcinoma in a
pair of male identical twins. The cancers in these twins presented with
strikingly similar ages of onset, histopathologic features, and sites of
metastasis.
After adjustment for age, sex, race, and smoking, the first-degree relatives
of lung-cancer patients and of patients with chronic obstructive pulmonary
disease have been shown by Cohen et al. (21) to have significantly higher
rates of impaired forced expiration than first-degree relatives of patients
with non-pulmonary disease. Similarly, Guirgis, et al. (22) reported an
increased frequencyof pulmonary diseases in the relatives of lung cancer
patients. These findings suggest*that lung cancer and chronic obstructive
pulmonary disease may share a common familiar component.
There may be genetically determined metabolic differences between lung cancer
patients and matched controls. Ayesh et al. (23) have reported differences in
the metabolic pathway of debrisoquine 4-hydroxylation in a white English
population. They demonstrated that lung cancer patients showed a
preponderance of probable homozygous dominant extensive metabolizers (78.8%)
with a few recessive poor metabolizers (1.6%) compared with matched controls
(27.8% and 9.0% respectively). These authors concludE:d that the gene
controlling debrisoquine 4-hydroxylation may be a genetic determinant of
susceptibility to lung cancer. Caporaso et al. (24,25) have recently
confirmed these observations in a group of white and black American patients.
They have estimated that extensive metabolizers are al; 4.5 times the risk for
developing lung cancer compared with poor metabolizern.
4

ENVIRONMENTAL TOBACCO SNOKE:
A CONPENDItN OF TECHNICAL INFORMATION
V
Section/Page/Line Specific Co=ents
ETS and Cancer/Page 42/Line 2 (Continued)
Kellermann has reported that the inducibility of aryl hydrocarbon hydroxylase
(AHH) in human lymphocytes is correlated with an increased risk of the
occurrence of bronchogenic carcinoma (26). The use of lymphocyte AHH
induction as an indicator of genetically controlled metabolic activation of
chemical carcinogens in the lungs is based on the assumption that induction is
similarly regulated in different tissues.
Dosaka and colleagues (27) have studied the inducibility of sister chromatid
exchanges (SCEs) by benzo(a)pyrene in cultured peripheral blood lymphocytes
from 15 untreated lung cancer patients and 25 healthy persons including 11
high - and 14 low - cancer-risk individuals as classified by family history.
After exposure to benzo(a)pyrene, the lymphocytes of lung cancer patients and
high-risk individuals exhibited significantly increased SCE rates than those
of low-risk persons. These authors have suggested that lymphocytes of high-
risk individuals may be more susceptible to benzo(a)pyrene induced DNA damage
and therefore to cancer.
The spontaneous transformation of human skin fibroblasts from three lung
cancer patients was observed by Azzarone et al. (28) in 1976. Rudiger et al.
(29) have also reported spontaneously increased SCE r<<tes in the fibroblasts
from lung cancer patients.
Several studies have shown differences in HLA frequenc':es between lung cancer
patients and the normal population. Ford, Newman, and Mackintosh (30) found a
high relative risk of being HLA-BW22-positive and having lung cancer. Markman
et al. (31) found individuals with the HLA-BW44 (HLA-Ba2) allele to be
significantly over-represented in a patient population with small cell
carcinoma of the lung compared to a control population (52% versus 25%,
N.001). Mottironi and Banks (32) showed that AW33 had a significant
difference in antigen frequency between a lung cancer population and controls.
However, none of these correlations has been strong ernwgh to use HLA typing
to screen patients for susceptibility to lung cancer.
Heighway et al. (33) investigated the influence of polymorphic variants of the
human c-Ha-ras gene on predisposition to lung cancer. They found an abnormal
allele distribution of the c-Ha-ras gene in individuals with non-small cell
carcinoma of the lung compared to both control and small cell carcinoma of the
lung patients. These authors have suggested that this difference may
represent a"degree of genetic predisposition" to non-small cell carcinoma of
the lung.
Another way to study the question of genetic predisposition to lung cancer
5

ENVIRONMENTAL TOBACCO SMOKE:
A COMPEHDIUN OF TECHNICAL INFORMATION
I
U
Section/Page/Line Specific Comments
ETS and Cancer/Page 42/Line 2 (Continued)
involves the identification and isolation of oncogenes i:apable of inducing
malignant transformation. Yokota et al. (34) showed that the c-erbB-2 gene
was amplified in 5 of 63 adenocarcinomas and in one of -the 38 other types of
tumors studied. These authors have suggested that the arotein products of the
amplified c-erbB-2 gene may play a role in the evolution of adenocarcinomas.
Whang-Peng et al. (35) have reported a nonrandom chromosomal abnormality (a
common deletion of the short arm of chromosome #3) in human small cell lung
cancer. The expression of proteins encoded by ras oncogenes was examined by
Tanaka et al. (36) in several types of lung cancer. PrDteins related to ras
genes were detected in squamous cell carcinoma, small cell carcinoma, and
adenocarcinoma. Individual differences in oncogene activation as a response
to environmental insult may be an important determinant of susceptibility to
lung cancer.
The National Cancer Institute currently has a major research program on
genetic typing and lung cancer. NCI Director Samuel Broder has formed a
committee to bring this gene research to clinical practice as quickly as
possible (37,38).
In summary, the evidence for the existence of a genetic predisposition for the
development of lung cancer comes from several sources: family histories, case
studies, epidemiology, biochemical measurements and geretic studies.
ETS and Cancer/Page 42/Line 6
The statement "Animal and human studies suggest that law consumption of
Vitamin A or its precursor, beta-carotene, may also increase lung cancer risk"
downplays a significant body of literature on the assoc:iation between diet and
lung cancer risk. Zeigler (39) has recently written a literature review on
the association between low levels of serum or plasma beta-carotene and lung
cancer risk.
Several of these dietary studies have reported relativc risks for lung cancer
much larger than those reported in ETS studies. For example, Menkes et al.
(40) reported that "A strong inverse association between serum beta-carotene
and the risk of squamous-cell carcinoma of the lung wa:: observed (relative
adds, 4.30: 95 percent confidence limits, 1.38 and 13.41)".
Dietary factors other than beta-carotene levels have also been associated with
lung cancer risk. Irv 1987, Wynder et al. (41) reportei that in an
international comparison study "calories from dietary fat were highly
6
~

ENYIRONMENTAL TOBACCO SMOKE:
A CONPENDIIAN OF TECMiICAL INFORMATION
iJ
h
i
Section/Page/Line Specific Comments
ETS and Cancer/Page 42/Line 6(Continued)
significantly associated-(P<.001) with lung cancer mortality. This finding
was obtained after accounting for disappearance data for tobacco (P<.001)..."
In addition, Goodman et al. (42) have reported a"sign-ificant positive
association of dietary cholesterol and the risk of lung cancer in men, but not
in women". Therefore, dietary fat intake is a risk factor for lung cancer.
ETS and Cancer/Page 42LLine 26-34
This paragraph states that epidemiologists "determine the causes of disease by
studying populations" and "identify the causes of disease". Epidemiologists
study "associations" of risk factors with diseases. They do not determine
"causes". Sir Richard Doll (43) has commented on this inherent limitation of
epidemiology, "Two methods have been commonly used - the retrospective,
starting from affected patients and unaffected controls, and the prospective,
starting from subjects with varying degrees of exposure to the agent under
study. Both methods have their advantages and disadvantages; but neither can
overcome completely the difficulty that any relationship that is found may be
a secondary one and that the suspected agent may itself be associated with
another which is, in fact, the true carcinogen."
ETS and Cancer/Page 43/Line 22
This paragraph on the misdiagnosis of lung cancer omits the important work of
McFarlane, Feinstein, and Wells (44-46).
ETS and Cancer/Page 43-45LSection entitled "EDidemiolaaical Evidence on
Involuntary Smokin4.and Lung Cancer"
There are significant differences in lifestyle between smokers and nonsmokers.
Smokers consume a diet significantly higher in saturated fat and lower in
fruits and vegetables than nonsmokers (47-49). Smokers exercise significantly
less than nonsmokers (50). They also sleep less than nonsmokers (51).
There are also significant differences in lifestyle between the spouses of
smokers and the spouses of nonsmokers. The following abstract is excerpted
from Perusse et al.'s (52) paper entitled "Familial Aggregation in Physical
7

ENVIRONMENTAL TOBACCO SMOKE:
A COMPENDIUM OF TECHNICAL INFORMATION
:NO
Section/Page/Line Specific Coo~nents
ETS and Cancer/Page 43-45/Section entitled "Eaidemiological Evidence on
Involuntary Smoking and Lung Cancer" (Continued)
Fitness, Coronary Heart Disease Risk Factors, and Pulmmary Function
Measurements":
"In order to test for the presence of familiar aggregation in physical fitness
and coronary heart disease risk factors, body fat, subnaximal power output,
muscular strength, muscul-ar endurance, blood pressure, pulmonary functions,
and several blood biochemical variables were measured in 304 nuclear families
living in the Quebec city area. Analysis of variance indicated a larger
between-family than within-family variation for all the variables. When all
members of nuclear families were considered, intraclass correlations ranged
from 0.21 to 0.34 (P < 0.01). Interclass correlations computed for various
pairs of relatives revealed significant parent-child and sibling correlations
for all the variables (0.14 <_ r<_ 0.55; P<_ 0.01). On the other hand, spousal
correlations tended to be lower but significant (0.10 < r< 0.30; P< 0.05)
for all variables except subcutaneous fat and hemoglobin concentration. These
results suggest that heredity and common lifestyle shared by members of
nuclear families are responsible for the familial aggregation of physical
fitness, coronary heart disease risk factors, and pulnionary functions. The
findings also support the notion of considering the nUclear family as a unit
of intervention in the application of preventive measures aimed at the
reduction of several risk factors."
Sidney et al. (53) recently reported that the self-reported mean dietary
intake of carotene is lower in nonsmokers exposed to ETS at home than in
nonsmokers not exposed to ETS at home. These authors stated, "We know of no
studies that have controlled for blood levels of caroi:enoids in the analysis
of this relation...". In addition, Miyamoto et al. (!i4) has reported
decreased levels of serum selenium and Vitamin E in the families of lung
cancer patients.
All of the studies described in this section and in the next section (ETS and
cancer at other sites) suffer from the same limitation - the inability to
control for the contribution of confounding variables to relative risk
estimates. As previously described in this review, there are a large number
of risk factors for lung cancer which exceed the National Research Council's
259'o risk increase estimate for exposure to ETS. The risk factors already
discussed include occupational exposures, genetic predisposition, high
saturated fat intake, and low intake of beta-carotene and other antioxidant
vitamins. There are many other reported risk factors for lung cancer:
tuberculosis, reproductive history in female adenocarcinoma patients,
periodontal disease, and even owning pet birds. Lifestyle differences between
8

ENYIRONNENTAL TOBACCO SNOKE:
A CONPENDIUM OF TECFWICAL INFORNATION
Section/Page/Line Specific Comments
ETS and Cancer/Page 43-45/Section entitled 'Epidemioloaical Evidence on''
Involuntary Smoking and Lung Cancer" (Continued)
,
smokers and nonsmokers are significant. Lifestyle differences between the
spouses of smokers and the spouses of nonsmokers also appear to be
significant. None of the studies associating exposure to ETS with cancer have
controlled for these lifestyle differences.
JJ
I
ii
L
~ ~

References
1. Watkin S. Temporal demographic and epidemiologic
variation in histologic subtypes of lung cancer: a
literature review. Lung Cancer 5: 69-81, 1989.
2. Robbins S., et al. Pathologic Basis of Disease 755.
Third edition. Saunders, 1984.
3. Schneiderman M, Davis D. Letter to the editor: Lung
cancer that is not attibutable to smoking. JAMA 261(18):
2635-36, 1989.
4. Table on welding and lung cancer risk (attached).
Referencing:
Lerchen M, Wiggins C, Samet J. Lung cancer and
occupation in New Mexico. JNCI 79(4): 639-645, 1987.
Buiatti E, Kriebel D, Geddes M, Santucci M, and Pucci N.
A case control study of lung cancer in Florence, Italy I;
Occupational risk factors. J. Epidem. & Comm. Health 39:
244-250, 1985.
Buiatti E, Kriebel D, Geddes M, Santucci M, and Pucci N.
A case control study of lung cancer in Florence, Italy
II; Effect of migration from the south. J. Epidem. &
Comm. Health 39: 251-255, 1985.
Tola S, et al. Cancer incidence among shipyard and
machine shop workers. Scand. J. Work. Environ. Health
13(2): 180, 1987.
Hull C, et al. Case-control study of lung cancer in Los
Angeles County welders. Am. J. Indust. Med. 16: 103-112,
1989.
Sjogren B, Gustavsson A, Hedstrom L. Mortality in two
cohorts of welders exposed to high- and low-levels of
hexavalent chromium. Scand. J. Work. Environ. Health 13:
247-251, 1987.
5., Table on painting and lung cancer risk (attached).
Referencing:
Zahm S, Brownson R, Chang J, Davis J. Study of lung
cancer histologic types, occupation, and smoking in
Missouri. Am. J. Indus. Med. 15: 565-578, 1989.
Lerchen M, Wiggins C, Samet J. Lung cancer and
occupation in New Mexico. JNCI 79(4): 639-645; 1987.
10

1'i I
6.
7.
~ 8.
9.
10.
11.
12.
f3
I( 13.
~ 14.
15.
16.
I 17.
Engholm G, Englund A, Lowing-H. Cancer incidence and
mortality among Swedish painters. Scand. J. Work.
Environ. Health 13(2): 181, 1987.
Vineis P et al. Proportion of lung cancers in males, due
to occupation in different areas of t:he USA. Int. J.
Cancer 42: 851-856, 1988.
Garshick E et al. A retrospective cohort study of lung
cancer and diesel exhaust exposure in railroad workers.
Am. Rev. Respir. Dis. 137: 820-825, ].988.
Becher H et al. Lung cancer, smoking, and employment in
foundries. Scand J. Work. Environ. F[ealth 15: 38-42,
1989.
Beaumont J et al. Lung cancer morta].ity in workers
exposed to sulfuric acid mist and other acid mists. JNCI
79(5): 911-921, 1987.
Steenland K, and Beaumont J. Further follow-up and
adjustment for smoking in a study of lung cancer and acid
mists. Am. J. of Indus. Med. 16: 347-354, 1989. '
Thomas T, and Stewart P. Mortality from lung cancer and
respiratory disease among pottery workers exposed to
silica and talc. Am. J. Epidem. 12511): 35-43, 1987.
Forastiere F, et al. Silica, silicosis and lung cancer
among ceramic workers: a case-referent study. Am. J.
Indus. Med. 10: 363-370, 1986.
Zhang Z-F, Yu S-Z, Li W-X, Choi BCK. Smoking,
occupational exposure to rubber, and lung cancer. Brit.
J. Indus. Med. 46: 12-15, 1989.
McDuffie H, Klaassen D, Cockcroft D, and Dosman J.
Farming and exposure to chemicals in male lung cancer
patients and their siblings. J. Occup. Med. 30(1):
55-59, 1988.
Tokuhata GK, Lilienfeld AM. Familia:. aggregation of lung
cancer in humans. JNCI 30: 289-312, 1963.
Tokuhata GK, Lilienfeld AM. Familia:. aggregation of lung
- cancer among hospital patients. Pub:.ic Health Reports
78: 277-283, 1963.
Ooi WL, Elston RC, Chen VW, Bailey-W::1son JE, Rothschild
H. Increased familial risk for lung cancer. JNCI 76:
217-222, 1986.
11

n
4
18. Samet JM, Humble CG, Pathak DR. Personal and family
history of respiratory disease and lung cancer risk. Am.
Rev. Resp. Dis. 134: 466-470, 1986.
19. McDuffie HH, Klaasen DJ, Dosman JA. Female-male
differences in patients with primary lung cancer. Cancer
59: 1825-1830, 1987.
20. Joishy SK, Cooper RA, Rowley PT. Alveolar cell carcinoma
in identical twins. Annals of Internal Medicine 87:
447-450, 1977.
21. Cohen BH, Graves CG, Levy-DA, et al. A common familial
component in lung cancer and chronic obstructive
pulmonary disease. Lancet, Sept. 10: 523-526, 1977.
22. Guirgis HA, Lynch HT, Harris RE, et ii. Familial
aggregation of lung cancer and other pulmonary diseases
(Abstract). Int. Congress Series 397: 77. Amsterdam,
Excerpta Medica, 1976. -
k-A 23.* Ayesh R, Idel JR, Ritchie JC, Crothers MJ, Hetzel M.
Metabolic oxidation phenotypes as mal-kers for -
susceptibility to lung cancer. Nature 312: 169-70, 1984.
24. Caporaso N, et al. Lung cancer risk, occupational
exposure, and the debrisoquine metabolic phenotype.
Cancer Research 49: 3675-3679, 1989.
25. Caporaso N, et a. The distribution of bebrisoquine
metabolic phenotypes and implications for the suggested
association with lung cancer risk. Genetic Epidem. 6(4):
517-524, 1989.
26. Kellermann GH. Genetic control of carcinogen metabolism
in man. Int'l Agency for Research on Cancer 297-317,
1976.
27. Dosaka H, Abe S, Sasaki M, Miyamota H, Kawakami Y.
Sister chromatid exchange induction by benzo(a)pyrene in
cultured peripheral blood lymphocytes of lung cancer
patients and healthy individuals with or without familial
history of neoplasms. Int'l J. Cancer 39: 329-332, 1987.
28. Azzarone B, Pedulla D, Romanzi CA. 3pontaneous
;
transformation of human skin fibroblasts derived from
neoplastic patients. Nature 262: 74-75, 1976.
29. Rudiger HW, Harder W, Maack P, Kohl :?V, Schmitt-Preuz U.
r!
Decreased rate of benzo(a)pyrene-induced sister chromatid
exchange in fibroblast cultures from patients with lung
cancer. J. Cancer Res. Clin Oncol. 102: 169-75, 1981.
12

t
~. I
30.
31.
i 32.
33.
34.
35.
,, ?
Ford CHJ, Newman CE, Mackintosh P. F[LA frequency and-
prognosis in lung cancer. Br. J. Cancer 43: 610-614,
1981.
Markman M, Braine HG, Abeloff MD. Histocompatibility
antigens in small cell carcinoma of the lung. Cancer 54:
1943-1945, 1984.
Mottironi VD, Banks S. HLA and survival in lung cancer.
FASEB Proceedings 42: 404, 1983.
Heighway J, Thatcher N, Cerny T, Has].eton PS. Genetic
predisposition to human lung cancer. Br. J. Cancer 53:
453-457, 1986.
Yokota J, Toyoshima K, Sugimura T, et: al. Amplification
of c-erbB-2-oncogene in human adenocarcinomas in vivo.
The Lancet, April 5: 765-766, 1986.
Whang-Peng J, Bunn PA, Kao-Shan CS, et al. A nonrandom
chromosomal abnormality, del 3p (14-23), in human small
cell lung cancer (SCLC). Cancer Genetics and
Cytogenetics 6: 119-134, 1982.
36.* Tanaka T, Slamon DJ, Battifora H, Cline MJ. Expression
of p21 ras oncoproteins in human cancers. Cancer
Research 46: 1465-1470, 1985.
37. Genetic Typing and Lung Cancer. Arti.cle excerpted from
New York Times, 5/16/89.
38. Minna J. Genetic events in the pathogenesis of lung
cancer. Proceedings at the 5th World Conference on Lung
Cancer., Chest 96: 17s-23s, 1989.
39. Ziegler R. A review of epidemiologic evidence that
carotenoids reduce the risk of cancer. Symposium --
Biolgocial actions of carotenoids: 1:.6-122, 1988.
40. Menkes M, et al. Serum beta-carotene, vitamins A and E,
selenium, and the risk of lung cancer. New Engl. J. Med.
315(20): 1250-1254, 1986.
41. Wynder E, Hebert J, Kabat G. Association of dietary fat
- and lung cancer. JNCI 79(4): 631-637, 1987.
42. Goodman M, Kolonel L, Yoshizawa C, and Hankin J. The
effect of, dietary choloesterol and fat on the risk of
lung cancer in Hawaii. Am. J. Epidern. 128(6): 1241-1255,
1988.
43. Doll,.R. Prevent.ion -of Cancer.: Pointers from-..
Epidemiology 17. 1967.
13
~
~

44. McFarlane M, Feinstein A, Wells C. Dlecropsy-evidence of
detection bias in the diagnosis of lL.ng cancer. Arch:
Intern. Med. 146: 1695-1698, 1986.
45. McFarlane M, Feinstein A, Wells C, Cr.an C. The
epidemiologic necropsy: unexpected detections,
demographic selections, and changing rates of lung
cancer. JAMA 258(3): 331-338, 1987.
46. Wells C and Feinstein A. Detection bias in the
diagnostic pursuit of lung cancer. Pn. J. Epidem.
128(5): 1016-1026, 1988.
47. Whichelow M, Golding J, Treasure F. Comparison of some
dietary habits of smokers and nonsmokers. Br. J.
Addiction 83: 295-304, 1988.
48. Shibata A, et al. Serum concentration of beta-carotene
and intake frequency of green-yellow vegetables among
healthy inhabitants of Japan. Int'l J. Cancer 44: 48-52,
1989.
49. Hirayama, T. Dietary habits in smoke!rs. In: Statistical
Methods in Cancer Research 93-94 (Blot W, Hirayama T, and
Hoel D, eds.) 1984.
50. Lazarus N, et al. Smoking and body mass in the natural
history of physical activity: prospective evidence from
the Alameda County Study, 1965-1974. Am. J. Prev. Med.
5(3): 127-135, 1989.
51. Edington, D. Smoking and habits. Study reported by the
University of Michigan News and Information Services
Department, June 29, 1988.
52. Perusse L, et al. Familial aggregation in physical
fitness: coronary heart disease risk factors, and
pulmonary function measurements. Prew. Med. 16: 607-615,
1987.
53. Sidney S, et al. Dietary intake of carotene in
nonsmokers with and without passive smoking at home. Am.
J. Epidem. 129(6): 1305-1309, 1989.
54. Miyamoto H, et al. Serum seleniuni arid vitamin E
concentrations in families of lung eancer patients.
Cancer 60: 1159-1162, 1987.
* -- Copy of article not provided.
14
